Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2017, Article ID 3921027, 5 pages
https://doi.org/10.1155/2017/3921027
Case Report

Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature

1Infectious Diseases Unit, Department of Medical and Surgical Science, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
2Research Centre for the Study of Hepatitis, University of Bologna, Bologna, Italy

Correspondence should be addressed to Viola Guardigni; moc.liamg@ingidraug.v

Received 1 August 2017; Revised 19 October 2017; Accepted 24 October 2017; Published 15 November 2017

Academic Editor: Mauro Vigano

Copyright © 2017 Renato Pascale et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Kim-Farley, “EPI for the 1990s,” Vaccine, vol. 10, no. 13, pp. 940–948, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Iqbal, R. M. Klevens, M. A. Kainer et al., “Epidemiology of Acute Hepatitis B in the United States from Population-Based Surveillance, 2006-2011,” Clinical Infectious Diseases, vol. 61, no. 4, pp. 584–592, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Sagnelli, M. Ciccozzi, M. Pisaturo et al., “The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy,” New Microbiologica, vol. 38, no. 2, pp. 137–147, 2015. View at Google Scholar · View at Scopus
  4. P. Lampertico, K. Agarwal, T. Berg et al., “EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection,” Journal of Hepatology, vol. 67, no. 2, pp. 370–398, 2017. View at Publisher · View at Google Scholar
  5. E. M. Sokal, M. Paganelli, S. Wirth et al., “Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition,” Journal of Hepatology, vol. 59, no. 4, pp. 814–829, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-Y. Chen, Y.-H. Ni, H.-L. Chen, F. L. Lu, and M.-H. Chang, “Lamivudine treatment in infantile fulminant hepatitis B,” Pediatrics International, vol. 52, no. 4, pp. 672–674, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Lok, “Drug therapy: Tenofovir,” Hepatology, vol. 52, no. 2, pp. 743–747, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Miyauchi, T. Kanda, M. Shinozaki et al., “Efficacy of lamivudine or entecavir against virological rebound after achieving HBV DNA negativity in chronic hepatitis B patients,” International Journal of Medical Sciences, vol. 10, no. 6, pp. 647–652, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Diamanti, M. R. Sartorelli, A. Alterio et al., “Successful Tenofovir Treatment for Fulminant Hepatitis B Infection in an Infant,” The Pediatric Infectious Disease Journal, vol. 30, no. 10, pp. 912–914, 2011. View at Publisher · View at Google Scholar
  10. K. F. Murray, L. Szenborn, J. Wysocki et al., “Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B,” Hepatology, vol. 56, no. 6, pp. 2018–2026, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Magalhães-Costa, L. Matos, P. Barreiro, and C. Chagas, “Fanconi syndrome and chronic renal failure in a chronic hepatitis B monoinfected patient treated with tenofovir,” Revista Espanola de Enfermedades Digestivas, vol. 107, no. 8, pp. 512–514, 2015. View at Google Scholar · View at Scopus
  12. D. M. Gracey, P. Snelling, P. McKenzie, and S. I. Strasser, “Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection,” Antiviral Therapy, vol. 18, no. 7, pp. 945–948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Viganò, A. Brocchieri, A. Spinetti et al., “Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal,” Journal of Clinical Virology, vol. 61, no. 4, pp. 600–603, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Samarkos, V. Theofanis, I. Eliadi, J. Vlachogiannakos, and A. Polyzos, “Tenofovir-associated Fanconi syndrome in a patient with chronic hepatitis B,” Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 3, p. 342, 2014, http://www.ncbi.nlm.nih.gov/pubmed/25267967. View at Google Scholar
  15. H. S. Hwang, C. W. Park, and M. J. Song, “Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection,” Hepatology, vol. 62, no. 4, pp. 1318–1320, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Hall, P. Bass, and R. J. Unwin, “Drug-induced renal fanconi syndrome,” QJM: An International Journal of Medicine, vol. 107, no. 4, pp. 261–269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Aurpibul and T. Puthanakit, “Review of tenofovir use in HIV-infected children,” Pediatric Infectious Disease Journal, vol. 34, no. 4, pp. 383–391, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Goicoechea, S. Liu, B. Best et al., “Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy,” The Journal of Infectious Diseases, vol. 197, no. 1, pp. 102–108, 2008. View at Publisher · View at Google Scholar
  19. M. Purswani, K. Patel, J. B. Kopp et al., “Tenofovir Treatment Duration Predicts Proteinuria in a Multiethnic United States Cohort of Children and Adolescents With Perinatal HIV-1 Infection,” The Pediatric Infectious Disease Journal, vol. 32, no. 5, pp. 495–500, 2013. View at Publisher · View at Google Scholar
  20. F. Conti, G. Vitale, C. Cursaro, M. Bernardi, and P. Andreone, “Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection,” Annals of Hepatology, vol. 15, no. 2, pp. 273–276, 2016. View at Publisher · View at Google Scholar
  21. M. Filippelli, E. Lionetti, A. Gennaro et al., “Hepatitis B vaccine by intradermal route in non responder patients: An update,” World Journal of Gastroenterology, vol. 20, no. 30, pp. 10383–10394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Park, J. Markowitz, M. Pettei et al., “Failure to Respond to Hepatitis B Vaccine in Children With Celiac Disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 44, no. 4, pp. 431–435, 2007. View at Publisher · View at Google Scholar
  23. J. Chen, Z. Liang, F. Lu et al., “Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine,” Vaccine, vol. 29, no. 4, pp. 706–711, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. L. Perry, R. D. Pearson, and J. Jagger, “Infected health care workers and patient safety: A double standard,” American Journal of Infection Control, vol. 34, no. 5, pp. 313–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Rosenthal, “Another drug in the armamentarium to combat hepatitis B virus in adolescents,” Hepatology, vol. 56, no. 6, pp. 2016-2017, 2012. View at Publisher · View at Google Scholar · View at Scopus